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Abstract Prenatal diagnosis of congenital lung anomalies
has increased in recent years as imaging methods have
benefitted from technical improvements. The purpose of
this pictorial essay is to illustrate typical imaging findings
of a wide spectrum of congenital lung anomalies on
prenatal US and MRI. Moreover, we propose an algorithm
based on imaging findings to facilitate the differential
diagnosis, and suggest a follow-up algorithm during
pregnancy and in the immediate postnatal period.
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Introduction
Congenital lung abnormalities (CLA) are a heterogeneous
group of pathologies consisting of isolated bronchopul-
monary anomalies, isolated vascular anomalies or a
combination of these. The most common CLAs include
congenital pulmonary airway malformation (CPAM),
bronchopulmonary sequestration (BPS), bronchial atre-
sia, bronchogenic cyst and congenital lobar overinflation
(CLO), also known as lobar emphysema [1]. These
entities account for >95% of all CLA. Prenatal diagnosis of
CLA has increased considerably in recent years due to more
widespread and improved prenatal US screening. Although in
most cases a well-performed US may provide a correct
diagnosis, complementary MRI is increasingly performed for
additional useful information in selected cases.
Prenatal diagnosis of CLA is difficult and often
confusing due to overlapping findings between different
lesions or to presence of complex, hybrid lesions with
combined vascular and bronchopulmonary abnormalities.
There is also great prenatal variability in clinical
evolution and outcome, from complete involution in
utero to progressive growth and secondary complica-
tions. The postnatal clinical spectrum ranges from the
asymptomatic child to the child with progressive, severe
respiratory distress requiring immediate intervention, but
despite it no clear indications for foetal MRI or for
postnatal imaging follow-up have been published.
The main purpose of this pictorial essay is to illustrate
the typical findings for a wide spectrum of CLAs with an
emphasis on p0renatal imaging. It is based on our own
experience during the last 10 years. We also propose a
diagnostic algorithm based on foetal US and MRI findings
(Fig. 1) and an algorithm for follow-up of any prenatally
detected lesions (Fig. 2)
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Prenatal diagnosis
In our hospital, routine US (including color Doppler)
pregnancy screening is conducted by the Department of
Obstetrics and Gynaecology and performed by gynaecolo-
gists with proven experience in prenatal diagnosis (Y.V., K.
F.). Standard US examinations include a detailed survey of
the foetal anatomy and an echocardiographic evaluation.
They are usually performed with a GE 730 Expert (General
Electric, Zipf, Austria) or an Acuson Sequoia (Sony IBL,
San Diego, CA) US scanner.
If a foetal lung lesion is detected, a complete evaluation
of both lungs is performed. Morphological description
includes anatomical location, extension, overall echogenic-
Fig. 1 Diagnostic algorithm based on foetal US and MRI findings
Fig. 2 Algorithm for follow-up of any prenatally detected lung lesions
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ity compared to normal foetal lung, homo/heterogeneity
and presence of solid/cystic/mixed components. We assess
the presence/absence of an abnormal feeding artery with
color Doppler. Lesions are then classified into three groups
(mostly solid, mostly cystic, mixed), and the most likely
differential diagnosis is suggested (Fig. 1).
After this initial exam, US controls are conducted at
regular intervals, usually every 4 weeks, to follow any
changes in size and to identify possible complications.
In case of hydrops or signs of obstruction due to
significant increase in the volume of the lesion, the
foetus will be scanned at least weekly. The most
important outcome criterion is the development of
hydrops, which is associated with an extremely high
risk of foetal or neonatal death [2–4]. Another predictor
of poor outcome is the presence of at least three of the
following criteria: large lesions (>50% of total foetal lung
volume involved in the abnormality), transverse mass
diameter-to-transverse chest diameter ratio>0.56 mea-
sured on an axial chest image in which the four-chamber
view of the heart is displayed [3], volume mass-to-head
circumference ratio>1.6 [4] or significant mass effect
(midline and/or intercostal lung herniation, mediastinal
shift, inversion of the ipsilateral diaphragm, severe
hypoplasia of the remaining lung) (Fig. 2).
The aims of supplementary foetal MRI are to (1) further
characterize the morphology of the lesion and its effects on
normal lung, (2) determine the volumes of both the normal
and abnormal lung and (3) further inform the discussion
about intervention (termination of pregnancy, immediate
delivery, thoracoamniotic shunting or puncture of a dom-
inant cyst, administration of prenatal corticosteroids for
treatment of severe small-cyst type CPAM, etc. [4, 5]). We
perform MRI with a 1.5-T scanner (Magnetom Symphony;
Siemens Medical Solutions, Erlangen, Germany) with a
phased-array body coil. Our preferred scan protocol is shown
in Table 1. It includes coronal, sagittal and transverse foetal
sections with T2-half-Fourier single-shot turbo spin-echo
(HASTE), steady-state free precession imaging (SSFP, true-
FISP) and a 3-D-spoiled gradient-echo sequence (VIBE).
Although we have recently added a diffusion-weighted
sequence, our experience with this is limited. The entire
examination does not usually exceed 30 min and is
performed without sedation. The MR images are read by
senior radiologists (L.A., F.G.) with experience in foetal
diagnostic imaging. The lesion is described similarly as on
US (Fig. 1).
Prenatal findings
Congenital pulmonary airway malformation
Formerly known as congenital cystic adenomatoid malfor-
mation (CCAM), CPAM is a heterogeneous group of
lesions caused by overgrowth of mesenchymal elements
and impairment of normal alveolar development. The term
CCAM is no longer considered appropriate because neither
cysts nor adenomatoid elements need to be present. Most
CPAMs are in the pulmonary vascular circuit and there is
normal communication with the bronchial tree. Cysts of
CPAM are lined by respiratory ciliated epithelium.
Stocker [6–8] initially defined three types and later
expanded it to five based on postnatal cyst-size and on the
histological resemblance with different segments of the
developing bronchial tree. Only three types of CPAM are
distinguishable at imaging and are therefore relevant for
this paper: type I has at least one dominant cyst>2 cm in
diameter; type II is composed of multiple, uniform small
cysts < 2 cm, and type III is solid or composed of microcysts
with diameter<0.2 cm [6, 7].
The exact aetiology remains unknown, but recently
Langston [9] suggested in utero airway obstruction as a
possible cause, hence proposing a more comprehensive
classification: a large-cyst type equivalent to the type I of
Stocker, and a small-cyst type, equivalent to Stocker type
II. By this classification, Stocker type III is considered a
form of pulmonary hyperplasia that should not be included
in the CPAM group [9]. This classification seems to be
more feasible for prenatal imaging.
On foetal US, CPAMs appear as hyperechoic, heteroge-
neous tissue with multiple hypoechoic cysts that may differ in
size and number (Figs. 3, 4). MRI returns higher signal than
normal lung on T2-weighted images. In the foetus, Stocker
type I lesions contain cysts >5 mm in diameter (Fig. 1)
whilst Stocker type II lesions contain smaller cysts (Fig. 4).
These cysts are easily recognisable on T2-weighted images
[10–12]. In large lesions, the expansion of the pathological
Table 1 Typical protocol (sequence parameters) used for foetal lung MRI in our center
Slice thickness (mm) TR (ms) TE (ms) Flip angle (degrees) Field of view (mm) Matrix
T2-HASTE 5 999 88 135 350×350 307×512
T2-TRUE FISP 5 6.44 3.22 70 350×262.5 230×512
T1-VIBE 4 3.69 1.6 12 255×340 192×256
Diffusion-weighted imaging 5 1,800 87 350×350 128×96
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lung may cause mediastinal shift and secondary compression
of the contralateral lung (Fig. 3).
In some foetuses with Stocker type II or III lesions, the
involved lung is homogeneously hyperechoic and hyperin-
tense compared to normal pulmonary parenchyma. These
lesions cannot be differentiated from other CLAs, such as
BPS and CLO [13].
CPAM of Stocker type III is debated. Although often
considered in the differential diagnosis for a homogeneous-
ly hyperintense CLA on imaging, it is rarely confirmed
histopathologically. Some consider it a different histopath-
ological entity altogether, often associated with bronchial
atresia and poor outcome [9]. Our experience supports this
hypothesis, as exemplified in a foetus with proximal atresia
Fig. 3 Large-cystic type
congenital pulmonary airway
malformation (CPAM). Sagittal
US with the foetal head to
the right (a) and balanced
steady-state free precession MRI
in the sagittal (b) and transverse
(c) plane in week 31 of gestation
show a large, heterogenous
lesion, involving most of the
right lung with macrocysts of
varying size. The affected lung
is overexpanded, causing
inversion of the ipsilateral
diaphragm, compression of
the right lower lobe (star)
and the left lung and significant
displacement of the heart (H).
Neonatal chest radiograph (d)
shows the increased volume of
the multicystic right lung and
secondary compression of the
left lung. The baby had severe
respiratory distress at birth, with
spontaneous pneumothorax
(note right chest drain). CT (e)
performed on day 3 show a
complex, multicystic lesion
involving the right upper and
middle lobes. The residual
pneumothorax (thick black
arrow) and the inserted chest
tube (thin black arrow) are
clearly identified
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of the right upper lobe bronchus, histologically proven
CPAM type III, mass effect, secondary severe hypoplasia of
the contralateral lung and a fatal outcome (Fig. 6).
The outcome of CPAM is unpredictable, but a characteristic
evolution in utero has been observed. Lesions, most com-
monly diagnosed during the second trimester, undergo some
increase in volume between 20 and 25 weeks’ gestation,
stabilising in volume toward the end of the second trimester
[14]. Subsequent regression has been observed in 20–50%
during mid-third trimester, usually at 29–34 weeks’ gestation
[4, 14]. Nevertheless, complete involution is extremely rare,
so small residual lesions are invariable observed in late
gestational MRI and postnatally.
Because of the great variability of lesions and their
potential regression in utero, morphological description
with foetal US and MRI seems to be the most useful way to
characterize lesions. Epelman et al. [15] have recently
recommended a description that includes anatomical loca-
tion, relationship with the bronchial tree, number of cysts
and the size of the largest cyst, among other parameters. In
Fig. 4 Small-cystic type
congenital pulmonary airway
malformation (CPAM). Trans-
verse US of the foetal chest (a)
at 21 weeks’ gestation shows a
heterogenous, mostly
hyperechoic mass containing
several small cysts within the
right hemithorax. There is
secondary mild mediastinal
shift (H, heart). T2-HASTE
foetal MRI image at 21 weeks’
gestation in transverse (b) and
sagittal (c) planes confirms the
presence of multiple,
similar-sized small cysts in
the right lower lobe. Postnatal
chest CT performed at 3 months
of age (d) and 3-D reconstruc-
tion image (Volume rendering
presets, Chest, Transparent lung,
version 2006; Advantage Work-
station, General Electric,
Milwaukee, WI, USA) (e) show
the multiple pulmonary cysts
and permit re-evaluation of the
extension of the lesion, which
now seems limited to the apical
and posterobasal segments of
the right lower lobe
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our opinion, this description is practical and transmits the
relevant information to the medical team in a comprehen-
sible way.
Bronchopulmonary sequestration
These masses contain nonfunctional lung tissue lacking a
normal communication with the tracheobronchial tree. BPS
can be extra- or intralobar, with extralobar lesions present-
ing a separate pleural investment. Both variants have
systemic arterial supply (distal thoracic or proximal
abdominal aorta or one of its major branches). Venous
drainage is via the pulmonary veins for the intralobar and
systemic veins (azygos or inferior vena cava) for the
extralobar type. These lesions are systemic arteriovenous
malformations and may cause cardiovascular symptoms if
hemodynamically significant [2].
Extralobar sequestration account for 25% of CLAs (Fig. 5)
and may be associated with other congenital systemic
anomalies, such as congenital diaphragmatic hernia or
cardiac abnormalities. This form may involute in utero. The
lesion is usually located at the left costophrenic angle,
inferior to the lung, or even within or below the diaphragm.
During pregnancy, the differential diagnosis of BPS in the
left subphrenic location includes neuroblastoma, adrenal
hemorrhage and other primary abdominal abnormalities.
Intralobar sequestration (accounting for around 75%) is
usually embedded in a normal lobe [13] (Figs. 5, 7). It is
increasingly identified at prenatal US. Langston [16]
recently suggested that it is a bronchial atresia with
systemic vascular supply [16].
At US, BPS is seen as a hyperechoic, relatively
homogeneous mass [1, 10, 12] (Fig. 5). On MRI, it is
typically well-defined with uniform high signal intensity
compared to normal lung on T2-weighted imaging. The
diagnosis is verified with color Doppler (and sometimes
with MRI) by the presence of an abnormal vascular supply
arising from the aorta or its major branches (Fig. 5) [11,
12]. If the vascular supply is not recognized, BPS is
indistinguishable from other congenital lung abnormalities,
such as CPAM, bronchial atresia and CLO [12, 17].
Bronchial atresia
This is a rare anomaly characterized by obliteration of a
segmental or subsegmental bronchus near its origin, with
normally developed distal structures. The apical and the
posterior segments of the left upper lobe are most frequently
involved. The bronchial obstruction causes accumulation of
the foetal lung fluid secreted by the distal alveoli, with
dilatation of the bronchi (bronchocele) and pulmonary
expansion distal to the obstruction. Recent studies have
Fig. 5 Intralobar sequestration.
Coronal US/color Doppler
image (a) of the foetal chest
at week 21 clearly demonstrates
the abnormal arterial supply to
the left lung base (arrow),
arising from the distal thoracic
aorta. Because of these
convincing findings, foetal MRI
was not performed. Transverse
(b) contrast-enhanced chest CT
at 3 months of age confirms the
abnormal arterial vascular
supply to the left posterobasal
segment. Sagittal (c) and
surface rendering (d)
reconstructions of the same CT
data show that there are in fact
two abnormal arteries (white
arrows) with significant
diameter compared to the aorta
and show the venous drainage of
the lesion via the pulmonary
veins (curved arrow)
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demonstrated a strong association between bronchial atresia
and other CLAs, including intralobar BPS and CPAM,
suggesting a common embryological origin [9, 16, 18].
Diagnosis of isolated bronchial atresia has increased in
recent years, but its prenatal characterization remains difficult.
Although both US and MRI provide good visualization of the
trachea and the main bronchi, segmental and subsegmental
bronchi are usually not well observed. Prenatally, the
lung (segment or subsegment) involved is expanded, has
increased echogenicity and returns high signal on T2-
weighted MRI (Fig. 6). In the case of proximal bronchial
obstruction, US and MRI may identify the central dilated
bronchus or bronchocele (Fig. 6). After birth, CT may
identify both the mucus-filled bronchus and the distal
surrounding air-trapping that is secondary to collateral
ventilation [1, 15].
Fig. 6 Bronchial atresia.
Transverse US (a) and
transverse (b) and coronal (c)
balanced steady-state free
precession MRI of the foetal
chest at 23 weeks’ gestation
show a hyperinflated,
homogeneously hyperechogenic
and hyperintense right lung
(star) occupying the majority of
the thorax and causing a
significant mediastinal shift,
with displacement of the heart
(H). The left lung is not
visualized. Observe the central
dilated tubular structure (arrow),
which corresponds to the dilated
right upper lobe bronchus
(bronchocele), distal to the
atretic segment. Note also the
significant ascites in c. The
pregnancy was terminated in
week 24. Macroscopic view of
the opened thorax at postmortem
(d) confirms the enormous
expansion of the right upper
lobe and secondary severe
compression of the contralateral
and the remaining ipsilateral
lung. The cut surface of the right
lung specimen (e) shows the
dilated distal bronchus (arrow)
and the regional overexpansion
of the lung parenchyma.
Postmortem confirmed the
proximal interruption of the
right upper lobe bronchus,
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Bronchogenic cysts
These account for 11–18% of mediastinal masses in infants
and children and for 40–50% of congenital intrathoracic
cysts [8]. They arise from abnormal branching of the
tracheobronchial tree and are typically located near the
carina (70%), but may be found paratracheally, in the hila
or even within the lung [1]. The cysts are lined with ciliated
respiratory columnar epithelium and filled with mucinous
material. Bronchial wall structures (e.g., smooth muscle and







(a) coronal (b) and
transverse (c) T2-HASTE MRI
of the foetal chest at 27 weeks’
gestation show a multilobulated,
homogeneous hyperechoic and
hyperintense multicystic lesion
at the apex of the left
lung, initially considered a
large-cystic type CPAM. d
Neonatal chest radiograph
demonstrates limited aeration
of the left upper lobe (arrow).
Coronal reconstruction (e) and
transverse section (f) from a
contrast-enhanced chest CT scan
at 6 months of age confirm the
fluid-filled mass in the left upper
lobe, with an abnormal arterial
supply, arising from the left
pulmonary artery (not from the
thoracic aorta, as is the rule in
sequestrations). Surface
rendering of the same CT (g)
reveals an additional
unsuspected, right anomalous
artery (arrow) arising from the
distal thoracic aorta and feeding
a normal right lower lobe with a
normal bronchial tree. This may
be considered a variant of a
intralobar sequestration (white
arrow). After segmentectomy
of the upper left lobe, specimen
showed a complex lesion,
with histological characteristics
of both bronchogenic cyst and
macrocystic CPAM
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cartilage) are usually identified. The differential diagnosis
includes oesophageal duplication cysts and neurenteric
cysts.
At prenatal US, bronchogenic cysts are usually anechoic,
uni- or bilocular well-defined masses in the middle
mediastinum or in the perihilar regions. At foetal MRI,
they have homogeneous high signal intensity on T2-
weighted images and low signal intensity on T1-weighted
images (Fig. 7). Occasionally, they may cause secondary
bronchial compression that causes morphological changes
in the lung distal to the obstruction: increase of volume and
retention of foetal lung fluid. The retained fluid is
homogeneously hyperechoic and is hyperintense on T2-
weighted MRI [12]. In case of bronchial obstruction, the
differential diagnosis includes bronchial atresia. Intrapul-
monary bronchogenic cysts are extremely difficult to
recognize prenatally (Fig. 7), and are easily misinterpreted
as macrocystic CPAM with a dominant cyst [13].
Congenital lobar overinflation or emphysema
CLO is characterized by progressive postnatal lobar expan-
sion that causes compression of normal lung. It is usually
caused by a focal cartilaginous bronchial wall abnormality [1].
The narrowed airway may postnatally exert a one-way valve
effect that results in air-trapping of the distal lung [17]. The
Fig. 8 Hybrid lesion:
large-cystic type congenital
pulmonary airway malformation
with dominant cyst and
bronchial atresia. Sagittal (a)
and coronal (b) balanced
steady-state free precession MRI
at 27 weeks’ gestation show a
large, apparently solitary cystic
lesion (arrowheads) within the
left hemithorax. The remaining
left lung has high signal inten-
sity (white arrow) compared
with the normal right lung
(star), a sign of retention of
pulmonary fluid. There is
secondary mediastinal shift (H,
heart). Chest radiograph (c) at
day 3 reveals the huge aerated
left lung cyst. Observe the
severe mediastinal shift.
Contrast-enhanced chest CT
performed at 6 months of age
(d) demonstrates additional tiny
peripherally located cysts (black
arrow). The main cyst is next to
the airway, causing obstruction
of the segmental bronchus and
distal segmental overinflation,
similar to findings in bronchial
atresia. Observe the dilatation of
the distal segment bronchus
(white arrow)
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pathogenesis and the dynamism of the lesion, with progres-
sive overinflation of the involved lung, explain the clinical
picture: increasing respiratory distress in the neonatal period
without any reported prenatal abnormality. Antenatal US and
MRI may demonstrate fluid-overloaded, expanded lung
tissue with homogeneous hyperechogenicity and MRI hyper-
intensity and may be difficult to distinguish from other CLA,
such as BPS, bronchial atresia and small cystic type CPAM.
In most cases, the lung structure is preserved, and stretched
vessels are observed [19].
Hybrid lesions
Elements of BPS and CPAM may coexist in hybrid lesions
(Figs. 7, 8). Bronchial atresia seems to be present in many
cases of BPS and CPAM [8, 16, 18–20]. Indeed, Langston
considers these patterns of lung maldevelopment to have a
common origin, being the consequence of an in utero
airway obstruction and representing a continuous spectrum
of anomalies rather than isolated, differentiated lesions. In
these cases, complete prenatal characterisation is almost
impossible and the suggested prenatal diagnosis would be
influenced most by the findings related to the main
anomaly. Therefore, postnatal imaging and, in most cases,
histopathological evaluation, may be required for a final
diagnosis (Figs. 7, 8).
Postnatal diagnosis
In the neonate, CLA may cause a range of clinical pictures,
from the asymptomatic child to severe respiratory distress
requiring immediate therapy or even an urgent operation.
Complete sonographic resolution of a lesion in utero and
absence of symptoms at birth are not necessarily proof of
complete anatomical normalization. Therefore, all patients
with antenatal detected CLA require detailed evaluation
with postnatal thoracic imaging [4, 14]. At our institution,
children with prenatally detected CLA are investigated
postnatally in accordance with a standard protocol that
includes plain chest radiographs for all patients at birth. It is
known that the progressive postnatal resorption of foetal
lung fluid is often associated with significant changes in the
morphology of some lesions in the first days of life. For
instance, CPAM initially appears (partly) solid and typical
air-filled cystic lesions appear only some days after birth.
Therefore, repeat chest radiographs during the first neonatal
week may be required depending on clinical status.
In the newborn, contrast-enhanced chest CT (CE-CT) is
performed only in case of respiratory distress. We do not
use CT in asymptomatic children in the immediate postnatal
period because of the delayed clearance of the normal foetal
pulmonary fluid and the immature renal function [15].
Asymptomatic children undergo CE-CT between 3 and
6 months of life to confirm the prenatal diagnosis, to re-
evaluate the extension of the lesion and to determine the origin
of the anomalous arterial supply in case of BPS. This informs
the discussion about indication for surgical resection.
Resection is the standard intervention for symptomatic
lesions, with lobectomy being the usual treatment of choice.
The correct care for asymptomatic children is debatable [2].
Although most authors advocate elective resection for
CPAM, BPS and bronchogenic cysts because of the risk
of complications, some recommend expectant long-term
care for asymptomatic children, in particular with CLO.
The timing of resection in asymptomatic children is also
debated. Most published papers suggest it be performed at
6–12 months of age, attempting to balance the increasing
risk of complications and the decreasing potential for
pulmonary regeneration with age [2].
Conclusions
CLA is a heterogeneous group of abnormalities with
significant overlap of imaging findings. Evidence suggest-
ing a common developmental origin for most CLAs has
been growing in recent years. Early airway obstruction in
utero is now considered the most probable underlying
embryological cause for a wide spectrum of pathologies,
with bronchial atresia present in many cases of BPS and
CPAM. Although prenatal diagnosis is difficult, an appro-
priate knowledge of the typical foetal US and MRI findings
of the most commonly occurring CLAs permits character-
ization of a significant number of these lesions in utero. In
particular, BPS with evident abnormal vascular supply,
large cystic type CPAM and centrally located bronchogenic
cysts. In foetal life, US is the most important, and usually
the only modality required for lesion characterisation and
for identification of unfavorable prognostic factors. Sup-
plementary MRI is useful in selected complicated cases as
it allows accurate determination of the location and
extension of the lesion and a better assessment of both the
normal and abnormal foetal lung, including lung volume
measurements.
Different CLAs may have similar prenatal imaging
appearances. Complex hybrid lesions are difficult to
characterize prenatally and require postnatal imaging or
even histopathological examination for a definite diagnosis.
Assessment of diagnosis and prognosis based on prenatal
imaging therefore needs to be succinct and cautious.
Information from prenatal studies needs to be passed on
in a comprehensible, descriptive way to facilitate the best
pregnancy and postnatal care.
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